JZP-430

CAS No. 1672691-74-5

JZP-430 ( —— )

Catalog No. M23752 CAS No. 1672691-74-5

JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 183 In Stock
10MG 276 In Stock
25MG 507 In Stock
50MG 714 In Stock
100MG 972 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    JZP-430
  • Note
    Research use only, not for human use.
  • Brief Description
    JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM).
  • Description
    JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM). It also shows ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL).
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAGL
  • Recptor
    ABHD6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1672691-74-5
  • Formula Weight
    354.5
  • Molecular Formula
    C16H26N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:90 mg/mL?(253.9 mM;?Need ultrasonic)
  • SMILES
    CN(C1CCCCCCC1)C(Oc1nsnc1N1CCOCC1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patel JZ, et al. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. ChemMedChem. 2015 Feb;10(2):253-65.
molnova catalog
related products
  • ABX-1431

    ABX-1431 (ABX1431) is a highly potent, selective, orally available, CNS-penetrant monoacylglycerol lipase (MGLL) with IC50 of 14 nM (hMGLL).

  • ABX-1431 hydrochlori...

    ABX-1431 (ABX1431) is a highly potent, selective, orally available, CNS-penetrant monoacylglycerol lipase (MGLL) with IC50 of 14 nM (hMGLL).

  • JZP-430

    JZP-430 is an effective, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) (IC50: 44 nM).